Adrenergic mechanisms in canine mesenteric circulation.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure; D003250:Constriction; D004106:Dilatation; D004285:Dogs; D004837:Epinephrine / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008638:Mesenteric Arteries / Q000502:physiology*; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011169:Portal Vein / Q000502:physiology; D011433:Propranolol / Q000494:pharmacology; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D012039:Regional Blood Flow; D013566:Sympathomimetics / Q000494:pharmacology*; D014666:Vasomotor System / Q000502:physiology*; D014667:Vasopressins / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D014667:Vasopressins; D010656:Phenylephrine; D011433:Propranolol; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine